For over fifty years, the Mario Negri Institute has conducted its research, training and the dissemination of information in accordance with its core values of independence, commitment to the scientific method and respect for ethics. For this reason, we have chosen to finance ourselves autonomously.
The institute accepts research funding regardless of whether it originates from the public or private sector and from commercial or non-profit entities, with the exception of funds that are intended to support the promotion of commercial products or to support anti-science ideologies or approaches that could have adverse effects on public and individual health.
The basic criteria for research projects are:
- That the studies be performed autonomously.
- That the data be owned by the institute until publication.
- That third-party rights with regards to patentability be respected.
Every researcher, according to their level of seniority, is responsible for obtaining the necessary fundsfor their own research and, at the same time, must use these resources appropriately.
In general, the Mario Negri Pharmacological Research Institute does not accept funding – from anysingle source – that exceeds 10% of its annual budget, to avoid being subject to undue influence.
*The impact factor reflects the average annual number of citations that articles published in the last two years have received in journals.
Intercheck web: applicazione web rivolta a medici e operatori sanitari a supporto della corretta prescrizione dei farmaci nell’anziano.
Servizio di informazioni rivolto alle mamme in gravidanza e allattamento sul corretto uso dei farmaci.
Servizio di informazioni rivolto a medici, operatori sanitari e cittadini sui piani terapeutici e le patologie rare.
Servizio di informazioni rivolto ai medici, agli operatori sanitari e ai pazienti sulle malattie renali e i trapianti.
Servizio di informazioni rivolto a medici, operatori sanitari e cittadini sull'uso corretto dei farmaci, sugli effetti collaterali e le interazioni nell'anziano.
